Introduction
Gram+anaerobic bacillus responsible for AAC,and 15-25%of cases of nosocomial AAD. If symptoms improve after a cessation of Antibiotics no need to treat.
Asymptomatic patient→no need to treat.
Treat as: -First episode(mild or moderate,severe) , .
-Recurrent episode of CDI Treatment of initial episode of CDI First ( mild or moderate) episode:Metro500mg TIDx10-14d , or Vanco125 mg PO QIDx10-14d which is indicated if :no response or intolerance or allergy to metronidazole, or in pregnancy.
First severe episode: Vanco 125mg PO QIDx10-14d
First severe complicated episode: Vanco500mgQID PO/NGT +Metro 500mg TID IV; ( Vanco> Metro in severe disease).
Recurrence rate after a first episode is 20%,and 45%after a second episode, and >60% after 2 or more recurrences.
Recurrent CDI is attributable to: -Relapse: endogenous persistence of the same strain of CD -Reinfection: acquisition of a new strain from an exogenous source -Selection of patients without protective immunity against CD Mean time to relapse is 14.5 days, whereas mean time to reinfection is 42.5 days Mechanisms for recurrent CDI are:
-inadequate immune response to CD toxins.
-persistant disruption of the normal colonic flora. Recurrence rates with fidaxomicin were lower(13%) compared to vancomycin(25%).
Tigecycline:analogue of minocycline used iv as adjunctive therapy for severe and refractory CDI.
CDI emerged as serious public health threat,with more virulent strains causing severe disease,and increased rate of incidence and prevalence.
Hypervirulent CD strains causes worlwide epidemics;CDI is primarily a preventable disease.
Preventing and controlling disease is a huge Challenge Diagnosis; CDI remains problematic,as no single test is sensitive or specific enough Diagnosis is confirmed by culture or the presence of CD toxins in stool, and by colonoscopy and histology.
First step in treatment is to discontinue offendic antibiotic.
Take Home Messages(2)
Metronidazole and vancomycin are the mainstays of treatment for both initial infection and first recurrence.
Vancomycin is recommended for severe or recurrent episode,and if intolerance for metronidazole,or in pregnancy For severe complicatedCDI→Vancomycin+Metronidazole For second recurrence, Vancomycin course (tapering and pulsed regimen) is recommended.
For subsequent recurrences, Fidaxomicin appears promising with less relapses compared to vancomycin.
